Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

26.3%

5 terminated/withdrawn out of 19 trials

Success Rate

61.5%

-25.0% vs industry average

Late-Stage Pipeline

16%

3 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(50.0%)
Phase 2
4(25.0%)
Phase 3
3(18.8%)
Phase 1
1(6.3%)
16Total
N/A(8)
Phase 2(4)
Phase 3(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT03915366Phase 2Completed

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Role: collaborator

NCT07120854Not ApplicableEnrolling By Invitation

Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.

Role: collaborator

NCT02596126Phase 3Completed

Secondary Prevention of Cardiovascular Disease in the Elderly Trial

Role: collaborator

NCT06435117Not ApplicableRecruiting

Cancer Prevention Among Individuals with Mental Ill-health: Patient Navigation for Primary Cancer Prevention

Role: collaborator

NCT06364631Phase 3Recruiting

CARE1 Pragmatic Clinical Trial

Role: collaborator

NCT03039751Phase 2Completed

Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris

Role: collaborator

NCT05406687Not ApplicableCompleted

Cancer Prevention and Early Detection Among the Homeless Population: The Health Navigator Model

Role: collaborator

NCT03570450Phase 1Recruiting

Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1

Role: collaborator

NCT05947786Unknown

Mpox Paediatric and Adolescent Clinical Study

Role: collaborator

NCT03962608Not ApplicableWithdrawn

Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis

Role: collaborator

NCT02849613Phase 2Withdrawn

Regenerative Stem Cell Therapy for Stroke in Europe

Role: collaborator

NCT02790996Phase 2Terminated

Neonatal Vancomycin Trial

Role: collaborator

NCT03202498Not ApplicableTerminated

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis

Role: collaborator

NCT02691546Completed

Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)

Role: collaborator

NCT03482232Completed

Consequences of Doing What Should Not be Done in Primary Care

Role: collaborator

NCT02509273Phase 3Terminated

Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients

Role: collaborator

NCT03181659Not ApplicableUnknown

Therapeutic Exercise and Therapeutic Patient Education With or Without Manual Therapy for Chronic Nonspecific Low Back Pain.

Role: collaborator

NCT02295397Not ApplicableCompleted

Integrated Approaches to Food Allergen and Allergy Risk Management

Role: collaborator

NCT02410408Not ApplicableCompleted

Apps to Reduce the Impact That Adverse Events Among Health Professionals

Role: collaborator

All 19 trials loaded